Novo Nordisk

TRETTEN

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Novo Nordisk

Tretten HCPCS:

J7181

HCPCS Code Descriptor:

Injection, factor xiii a-subunit, (recombinant), per iu

Category:

J Code

Tretten NDCs:

00169-7013-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Tretten CPT Codes:

Potential CPT administration codes for Tretten can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Tretten:

TRETTEN is a Hematology drug manufactured by Novo Nordisk and administered via the Intravenous route of administration. The J Code: J7181 is aligned to the drug TRETTEN.

ACCESS PRICING AND MORE BY REGISTERING

J7181 Added Date:

January 1, 2015

J7181 Effective Date:

January 1, 2023

J7181 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Tretten billing and coding information.
Tretten patient assistance information can be found through Novo Nordisk’s NovoCare at the URL: https://www.mynovosecure.com/resources.html
TRETTEN prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for TRETTEN. Please check back in a few weeks.